Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Baird Medical Investment HoldingsBDMD -2.86%17 Net Current Asset Value is $0.54 as of Dec. 2025, which is 90% below its 10-year median of 5.48. GuruFocus rates BDMD with a GF Score™ of 17/100. The stock has 7 warning signs investors should review. Among 566 Medical Devices & Instruments companies, Baird Medical Investment Holdings ranks better than 81.8% on this metric.
In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).
The historical rank and industry rank for Baird Medical Investment Holdings's Net Current Asset Value or its related term are showing as below:
BDMD'
s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 1.96 Med: 5.48 Max: 8.44
Current: 1.96
During the past 5 years, the highest Price-to-Net-Current-Asset-Value Ratio of Baird Medical Investment Holdings was 8.44. The lowest was 1.96. And the median was 5.48.
BDMD's Price-to-Net-Current-Asset-Value is ranked better than 81.8% of 566
companies
in the Medical Devices & Instruments industry
Industry Median: 4.785
vs BDMD: 1.96
Baird Medical Investment Holdings (NAS:BDMD) Net Current Asset Value Explanation
Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."
The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]
Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.
One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Grahams strategy produced similar results.
Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.
Baird Medical Investment Holdings Net Current Asset Value Related Terms
Baird Medical Investment Holdings Net Current Asset Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Baird Medical Investment Holdings Net Current Asset Value Chart
Baird Medical Investment Holdings Annual Data
Trend
Dec21
Dec22
Dec23
Dec24
Dec25
Net Current Asset Value
0.33
0.48
0.54
0.90
0.54
Baird Medical Investment Holdings Semi-Annual Data
BDMD vs TELA, NSPR, PAVM: Net Current Asset Value Comparison
For the Medical Devices subindustry, Baird Medical Investment Holdings's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Baird Medical Investment Holdings Price-to-Net-Current-Asset-Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Baird Medical Investment Holdings's Price-to-Net-Current-Asset-Value distribution charts can be found below:
* The bar in red indicates where Baird Medical Investment Holdings's Price-to-Net-Current-Asset-Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Net Current Asset Value of $0.54 mean?
Baird Medical Investment Holdings (BDMD) has a Net Current Asset Value of $0.54 as of Dec. 2025. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Baird Medical Investment Holdings and its competitors. This is 90% below median its historical median of 5.48. Over the past decade, Baird Medical Investment Holdings' Net Current Asset Value has ranged from 1.96 to 8.44. According to the industry distribution chart, Baird Medical Investment Holdings ranks #103 out of 566 companies in the Medical Devices & Instruments industry, placing it in the top 18.2%.
Is Baird Medical Investment Holdings' Net Current Asset Value too high?
Baird Medical Investment Holdings' current Net Current Asset Value of $0.54 is 90% below median its 10-year median of 5.48. Over the past 10 years, this metric has ranged from a low of 1.96 to a high of 8.44. The Medical Devices & Instruments industry median Net Current Asset Value is 4.79. Baird Medical Investment Holdings' value of $0.54 is 88.7% below this industry median. Based on the distribution chart, Baird Medical Investment Holdings ranks #103 out of 566 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Baird Medical Investment Holdings has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Baird Medical Investment Holdings' Net Current Asset Value compare to TELA and NSPR?
According to the Medical Devices & Instruments industry distribution chart, Baird Medical Investment Holdings ranks #103 out of 566 companies for Net Current Asset Value. This places Baird Medical Investment Holdings in the top 18% of its industry — outperforming the majority of peers. The industry median Net Current Asset Value is 4.79. Baird Medical Investment Holdings' value of $0.54 is 88.7% below this benchmark. Historically, Baird Medical Investment Holdings' own Net Current Asset Value has ranged from 1.96 to 8.44 over the past decade. While the company's 10-year median is 5.48 vs. the industry median of 4.79, Baird Medical Investment Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Current Asset Value for a Medical Devices & Instruments company?
The median Net Current Asset Value among Medical Devices & Instruments companies is 4.79, based on 566 companies in the industry. Companies in the top quartile (top 25%) have a Net Current Asset Value significantly above this median, while those in the bottom quartile fall well below. However, Net Current Asset Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Baird Medical Investment Holdings's current Net Current Asset Value of $0.54 is 88.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Current Asset Value mean?
A high Net Current Asset Value can signal that a stock is expensive relative to its fundamentals. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Baird Medical Investment Holdings and its competitors. For the Medical Devices & Instruments industry, the median Net Current Asset Value is 4.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Baird Medical Investment Holdings's current Net Current Asset Value is $0.54, which is 90% below median its own 10-year median of 5.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Baird Medical Investment Holdings stock overvalued right now?
Baird Medical Investment Holdings (BDMD) has a current Net Current Asset Value of $0.54. The current Net Current Asset Value is $0.54, which is 90% below median its 10-year median of 5.48 and 88.7% below the Medical Devices & Instruments industry median of 4.79. Baird Medical Investment Holdings' overall GF Score™ is 17/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Current Asset Value calculated?
Net Current Asset Value is calculated from a company's financial statements. For Baird Medical Investment Holdings (BDMD), the current Net Current Asset Value is $0.54 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Baird Medical Investment Holdings Business Description
Baird Medical Investment Holdings Ltd is a specialized healthcare innovator dedicated exclusively to thyroid-related diseases and a microwave ablation (MWA) medical device manufacturer and provider in China. The company combines clinical expertise with technologies to develop non-invasive treatment solutions. Its proprietary MWA medical devices are used for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps. Its core activities include the development and commercialization of thyroid microwave ablation systems and an active R&D pipeline of AI-integrated robotic systems, integrating hardware, software, and system-based solutions.
17GF Score
Get the complete analysis for BDMD
Net Current Asset Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BDMD has been successfully added to your 
